Somatropin (rDNA origin, Novo Nordisk)

生长激素（诺和诺德）

Report date: 2026/03/04 20:01:44

Base Information

Drug NameSomatropin (rDNA origin, Novo Nordisk)
Drug Alias NameSomatropinum (Novo Nordisk)Norditropin Nordiflex (Novo Nordisk)Norditropin SimpleXx (Novo Nordisk)Somatropine (Novo Nordisk)Somatropina (Novo Nordisk) +[18] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyIdiopathic short statureAnorexia Nervosa +[22] 
Global Approved IndicationsGrowth hormone deficiencyGrowth DisordersTurner Syndrome +[4] 
Approved Indications in ChinaGrowth hormone deficiencyGrowth Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date1999/06/22
Country/TerritoryCzechiaCanadaUnited States +[29] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk IncNovo Nordisk A/SNorthwell Health, Inc
Inactive CompaniesNational Institute On Aging (NIA)
Active IndicationsGrowth hormone deficiencyAthletic InjuriesFailure to Thrive +[9] 
Inactive IndicationsIdiopathic short statureAnorexia NervosaFractures, Bone +[13] 

Other Information

ATC CodeH01AC01
Related LinksWikipediaKEGG